SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

Morgan Stanley Maintains Overweight on Zealand Pharma, Raises Price Target to $32

Morgan Stanley maintains Zealand Pharma (NASDAQ:ZEAL) with a Overweight and raises the price target from $30 to $32.

Benzinga · -

Morgan Stanley maintains Zealand Pharma (NASDAQ:ZEAL) with a Overweight and raises the price target from $30 to $32.